BlackRock Institutional Trust’s Cytosorbents Corp CTSO Stock Holding History

BlackRock Institutional Trust’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$246K	Buy	45,157 +15,202	+51%	+$83.2K	﹤0.01%	3566
2016 Q3	$192K	Buy	29,955 +3,495	+13%	+$18.2K	﹤0.01%	3611
2016 Q2	$120K	Hold	26,460	–	–	﹤0.01%	3681
2016 Q1	$104K	Hold	26,460	–	–	﹤0.01%	3711
2015 Q4	$147K	Buy	26,460 +12,391	+88%	+$84.4K	﹤0.01%	3697
2015 Q3	$89K	Buy	14,069 +12,173	+642%	+$81.2K	﹤0.01%	3743
2015 Q2	$12K	Buy	+1,896	New	+$12.9K	﹤0.01%	3867

Other funds holding CTSO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Institutional Trust's CTSO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Cytosorbents Corp (CTSO) stake by 51% in Q4 2016, buying an estimated $83.2K and bringing the position to 45,157 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #3566.

BlackRock Institutional Trust first reported a position in CTSO in Q2 2015 and has held it in 7 quarters since. 38 funds tracked by Wall St. Rank hold CTSO as of Q4 2016.

BlackRock Institutional Trust held 45,157 shares of Cytosorbents Corp worth $246K as of Q4 2016.
BlackRock Institutional Trust bought 15,202 Cytosorbents Corp shares in Q4 2016, an estimated $83.2K.
Cytosorbents Corp made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3566 holding.
BlackRock Institutional Trust first reported a position in Cytosorbents Corp in Q2 2015 and has held it in 7 quarters since.
38 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.